Polymyalgia rheumatica and giant cell arteritis are related autoimmune conditions that occur primarily in older adults. This review highlights recent advances in their diagnosis and management.

MRI Magnetic resonance imaging findings are increased vessel wall thickness and edema, increased mural enhancement on post-contrast T 1 -weighted images and luminal stenosis on MR angiography.

Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...

An 80-year-old man presented repeatedly to his general practitioner with 3 months of unexplained persistent frontal headaches. CT head revealed no diagnosis. His dentist diagnosed his co-existing jaw ...

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

Upadacitinib 15 mg — but not 7.5 mg — alongside a glucocorticoid taper demonstrated superior efficacy to placebo with a ...

Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...

Patients with giant cell arteritis treated daily with prednisone were randomized to one of three different groups: the control group that received placebo medications; a group that received 7.5 ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a Phase 3 clinical trial.